
Why Conventional Acute Migraine Therapies Fall Short: Medication Overuse, Triptan Resistance, and Unmet Clinical Needs
Friday, September 11th 2026 - 2:35 PM (IST)
12 days to go
1.6k doctors attending
Friday, September 11th 2026 - 2:35 PM (IST)
About this session
Dr. Debashish Chowdhury chairs this insightful keynote session featuring Dr. Subhash Kaul. The discussion critically examines the limitations of traditional acute therapies, including medication overuse, triptan resistance, and persistent unmet clinical needs, setting the stage for a paradigm shift in migraine management.
Other details
Registration
Free
Duration
25 min
Replay
Yes
Certificate
No
Language
English
Explore other sessions
Disclaimer
This program is organized by Medflix and sponsored by Pfizer Limited. Pfizer shall not be responsible for any cancellation, postponement, delay, or disruption of the webcast arising from circumstances beyond its reasonable control, including but not limited to faculty unavailability, technical failures, internet connectivity issues, or platform-related disruptions. The views, opinions, and recommendations expressed by the faculty are their own and do not necessarily reflect those of Pfizer Limited, its parent, subsidiary, or affiliate entities. Pfizer makes no representation or warranty, express or implied, regarding the accuracy, completeness, or suitability of the information presented.
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory

